Cytotoxicity evaluation of extracts and fractions of five marine sponges from the Persian Gulf and HPLC fingerprint analysis of cytotoxic extracts

Asian Pacific Journal of Tropical Biomedicine

Volumn 5, Issue 11, 2015, Pages 896-901

  Mahdian, Davood ^a   Iranshahy, Milad ^a   Shakeri, Abolfazl ^a   Hoseini, Azar ^b   Yavari, Hoda ^a   Nazemi, Melika ^c   Iranshahi, Mehrdad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRANIAN FISHERIES RESEARCH ORGANIZATION   (Iran)

Author keywords

Cytotoxicity; HeLa; Marine sponges; MTT test; PC12

Indexed keywords

ALCOHOL; AXINELLA SINOXEA EXTRACT; CYTOTOXIC AGENT; DYSIDEA AVARA EXTRACT; HALICLONA TUBIFERA EXTRACT; HALICLONA VIOLACEA EXTRACT; IRCINIA ECHINATA EXTRACT; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; AXINELLA SINOXEA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DYSIDEA AVARA; FEMALE; HALICLONA TUBIFERA; HALICLONA VIOLACEA; HELA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IRCINIA ECHINATA; MEDITERRANEAN SEA; NONHUMAN; PC12 CELL LINE; PERSIAN GULF; PRIORITY JOURNAL; SPONGE (PORIFERA);

EID: 84952873058     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtb.2015.07.020     Document Type: Article

References (15)

1. Dalkic E., Wang X.W., Wright N., Chan C. Cancer-drug associations: a complex system. PLoS One 2010, 5:e10031.
2. Mahdian D., Shafiee-Nick R., Mousavi S.H. Different effects of adenylyl cyclase activators and phosphodiesterases inhibitors on cervical cancer (HeLa) and breast cancer (MCF-7) cells proliferation. Toxicol Mech Methods 2014, 24(4):307-314.
3. Zhou H., Zou P., Chen Z.C., You Y. A novel vicious cycle cascade in tumor chemotherapy. Med Hypotheses 2007, 69(6):1230-1233.
4. Sak K. Chemotherapy and dietary phytochemical agents. Chemother Res Pract 2012, 10.1155/2012/282570.
5. Li Y.X., Himaya S.W., Kim S.K. Triterpenoids of marine origin as anti-cancer agents. Molecules 2013, 18:7886-7909.
6. World Health Organization Cancer 2015, World Health Organization, Geneva, [Online] Available from:, [Accessed on 21st April, 2015]. http://www.who.int/mediacentre/factsheets/fs297/en/.
7. Nussbaumer P., Bazilian M., Modi V., Yumkella K.K. Measuring energy poverty: focusing on what matters 2011, University of Oxford, Oxford, [Online] Available from:, [Accessed on 15th May, 2015]. http://www.ophi.org.uk/wp-content/uploads/OPHI_WP_42_Measuring_Energy_Poverty1.pdf.
8. Monsuez J.J., Charniot J.C., Vignat N., Artigou J.Y. Cardiac side-effects of cancer chemotherapy. Int J Cardiol 2010, 144:3-15.
9. Dropcho E.J. The neurologic side effects of chemotherapeutic agents. Continuum (Minneap Minn) 2011, 17:95-112.
10. Lim H.K., Bae W., Lee H.S., Jung J. Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status. Biomed Res Int 2014, 10.1155/2014/413575.
11. Chairman K., Ranjit Singh A.J.A. Cytotoxic activity of sponge extract and cancer cell lines from selected sponges. Biomater Biomed 2013, 2:1-5.
12. Gordaliza M. Cytotoxic terpene quinones from marine sponges. Mar Drugs 2010, 8(12):2849-2870.
13. Solanki R., Khanna M., Lal R. Bioactive compounds from marine actinomycetes. Indian J Microbiol 2008, 48:410-431.
14. Facompré M., Tardy C., Bal-Mahieu C., Colson P., Perez C., Manzanares I., et al. Lamellarin D: a novel potent inhibitor of topoisomerase I. Cancer Res 2003, 63:7392-7399.
15. Li Y.X., Kim S.K. Triterpenoids as anticancer drugs from marine sponges. Handbook of anticancer drugs from marine origin 2015, Springer International Publishing, Switzerland. S.K. Kim (Ed.).